Literature DB >> 11730999

A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.

L Cozzi1, A Fogliata, A Lomax, A Bolsi.   

Abstract

BACKGROUND AND
PURPOSE: In this work, the potential benefits and limitations of different treatment techniques, based on mixed photon-electron beams, 3D conformal therapy, intensity modulated photons (IM) and protons (passively scattered and spot scanned), have been assessed using comparative treatment planning methods in a cohort of patients presenting with advanced head and neck tumours.
MATERIAL AND METHODS: Plans for five patients were computed for all modalities using CT scans to delineate target volume (PTV) and organs at risk (OAR) and to predict dose distributions. The prescribed dose to the PTV was 54 Gy, whilst the spinal cord was constrained to a maximum dose of 40.5 Gy for all techniques. Dose volume histograms were used for physical and biological evaluation, which included equivalent uniform dose (EUD) calculations.
RESULTS: Excluding the mixed photon-electron technique, PTV coverage was within the defined limits for all techniques, with protons providing significantly improved dose homogeneity, resulting in correspondingly higher EUD results. For the spinal cord, protons also provided the best sparing with maximum doses as low as 17 Gy. Whilst the IM plans were demonstrated to be significantly superior to non-modulated photon plans, they were found to be inferior to protons for both criteria. A similar result was found for the parotid glands. Although they are partially included in the treated volume there is a clear indication that protons, and to a lesser extent IM photons, could play an important role in preserving organ functionality with a consequent improvement of the patient's quality of life.
CONCLUSIONS: For advanced head and neck tumours, we have demonstrated that the use of IM photons or protons both have the potential to reduce the possibility of spinal cord toxicity. In addition, a substantial reduction of dose to the parotid glands through the use of protons enhances the interest for such a treatment modality in cases of advanced head and neck tumours. However, in terms of target coverage, the use of 3D conformal therapy, although somewhat inferior in quality to protons or IM photons, has been shown to be a reasonable alternative to the more advanced techniques. In contrast, the conventional technique of mixed photon and electron fields has been shown to be inferior to all other techniques for both target coverage and OAR involvement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730999     DOI: 10.1016/s0167-8140(01)00403-0

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  32 in total

1.  Radiotherapy for the future.

Authors:  Bleddyn Jones; Neil Burnet
Journal:  BMJ       Date:  2005-04-30

Review 2.  Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.

Authors:  Arjan Vissink; James B Mitchell; Bruce J Baum; Kirsten H Limesand; Siri Beier Jensen; Philip C Fox; Linda S Elting; Johannes A Langendijk; Robert P Coppes; Mary E Reyland
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-15       Impact factor: 7.038

Review 3.  The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature.

Authors:  Tara A van de Water; Hendrik P Bijl; Cornelis Schilstra; Madelon Pijls-Johannesma; Johannes A Langendijk
Journal:  Oncologist       Date:  2011-02-24

4.  PET/CT-guided treatment planning for paediatric cancer patients: a simulation study of proton and conventional photon therapy.

Authors:  J S Kornerup; N P Brodin; T Björk-Eriksson; C Birk Christensen; A Kiil-Berthelsen; M C Aznar; C Hollensen; E Markova; P Munck Af Rosenschöld
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

5.  Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice.

Authors:  Steven J Frank; James D Cox; Michael Gillin; Radhe Mohan; Adam S Garden; David I Rosenthal; G Brandon Gunn; Randal S Weber; Merrill S Kies; Jan S Lewin; Mark F Munsell; Matthew B Palmer; Narayan Sahoo; Xiaodong Zhang; Wei Liu; X Ronald Zhu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-05-24       Impact factor: 7.038

6.  Comparison of intensity-modulated radiotherapy, adaptive radiotherapy, proton radiotherapy, and adaptive proton radiotherapy for treatment of locally advanced head and neck cancer.

Authors:  Charles B Simone; David Ly; Tu D Dan; John Ondos; Holly Ning; Arnaud Belard; John O'Connell; Robert W Miller; Nicole L Simone
Journal:  Radiother Oncol       Date:  2011-06-12       Impact factor: 6.280

7.  Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.

Authors:  Paul B Romesser; Oren Cahlon; Eli D Scher; Eugen B Hug; Kevin Sine; Carl DeSelm; Jana L Fox; Dennis Mah; Madhur K Garg; John Han-Chih Chang; Nancy Y Lee
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-17       Impact factor: 7.038

8.  Future of Radiotherapy in Nasopharyngeal Carcinoma.

Authors:  Xue-Song Sun; Xiao-Yun Li; Qiu-Yan Chen; Lin-Quan Tang; Hai-Qiang Mai
Journal:  Br J Radiol       Date:  2019-07-09       Impact factor: 3.039

9.  Comparative study of dose distribution between carbon ion radiotherapy and photon radiotherapy for head and neck tumor.

Authors:  M Amirul Islam; Takeshi Yanagi; Jun-Etsu Mizoe; Hideyuki Mizuno; Hirohiko Tsujii
Journal:  Radiat Med       Date:  2008-09-04

Review 10.  Do we have enough evidence to implement particle therapy as standard treatment in lung cancer? A systematic literature review.

Authors:  Madelon Pijls-Johannesma; Janneke P C Grutters; Frank Verhaegen; Philippe Lambin; Dirk De Ruysscher
Journal:  Oncologist       Date:  2010-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.